$1.64 Billion is the total value of Consonance Capital Management LP's 35 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 70.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AUPH | Buy | AURINIA PHARMACEUTICALS INC | $134,236,000 | +881.5% | 6,625,671 | +158.7% | 8.19% | +505.5% |
| ARQL | Buy | ARQULE INC | $134,051,000 | +366.1% | 6,715,965 | +67.4% | 8.18% | +187.5% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $117,463,000 | +109.2% | 6,127,434 | +5.0% | 7.17% | +29.0% |
| EPZM | Buy | EPIZYME INC | $105,942,000 | +158.4% | 4,306,575 | +8.3% | 6.47% | +59.4% |
| UTHR | Sell | UNITED THERAPEUTICS CORP DEL | $80,969,000 | +4.9% | 919,263 | -5.0% | 4.94% | -35.3% |
| CCXI | Buy | CHEMOCENTRYX INC | $75,211,000 | +565.6% | 1,901,667 | +14.1% | 4.59% | +310.6% |
| ALGN | Sell | ALIGN TECHNOLOGY INC | $75,062,000 | +38.8% | 269,000 | -10.0% | 4.58% | -14.4% |
| KDMN | Buy | KADMON HLDGS INC | $70,859,000 | +162.9% | 15,642,064 | +46.3% | 4.32% | +62.2% |
| ITCI | Buy | INTRA CELLULAR THERAPIES INC | $67,762,000 | +45377.9% | 1,975,000 | +9775.0% | 4.14% | +27473.3% |
| QURE | Sell | UNIQURE NV | $66,575,000 | +18.4% | 929,036 | -35.0% | 4.06% | -27.0% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $63,217,000 | – | 604,604 | +100.0% | 3.86% | – |
| EXAS | New | EXACT SCIENCES CORP | $53,608,000 | – | 579,666 | +100.0% | 3.27% | – |
| AXGN | New | AXOGEN INC | $53,426,000 | – | 2,986,386 | +100.0% | 3.26% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $45,957,000 | +4983.7% | 356,145 | +2867.9% | 2.80% | +3051.7% |
| CDNA | Buy | CAREDX INC | $45,771,000 | +178.8% | 2,121,976 | +192.2% | 2.79% | +71.9% |
| OMER | Buy | OMEROS CORP | $45,029,000 | -2.6% | 3,195,796 | +12.9% | 2.75% | -39.9% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $41,778,000 | +36.7% | 1,509,327 | -10.1% | 2.55% | -15.7% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $39,238,000 | +10.0% | 2,363,724 | +10.2% | 2.40% | -32.1% |
| ASMB | New | ASSEMBLY BIOSCIENCES INC | $38,432,000 | – | 1,878,395 | +100.0% | 2.35% | – |
| RTRX | RETROPHIN INC | $32,865,000 | +22.5% | 2,314,421 | 0.0% | 2.01% | -24.4% | |
| TNDM | Sell | TANDEM DIABETES CARE INC | $32,842,000 | -45.5% | 550,956 | -46.1% | 2.00% | -66.4% |
| ISEE | New | IVERIC BIO INC | $29,398,000 | – | 3,426,365 | +100.0% | 1.79% | – |
| LMNL | New | LIMINAL BIOSCIENCES INC | $27,548,000 | – | 3,287,311 | +100.0% | 1.68% | – |
| VCEL | Sell | VERICEL CORP | $27,077,000 | -50.9% | 1,556,137 | -57.3% | 1.65% | -69.7% |
| New | APTOSE BIOSCIENCES INC | $27,058,000 | – | 4,772,190 | +100.0% | 1.65% | – | |
| PODD | INSULET CORP | $26,673,000 | +3.8% | 155,800 | 0.0% | 1.63% | -36.0% | |
| ADMA | Buy | ADMA BIOLOGICS INC | $20,668,000 | -9.2% | 5,166,961 | +1.0% | 1.26% | -44.0% |
| STAA | Sell | STAAR SURGICAL CO | $14,975,000 | -52.7% | 425,800 | -65.3% | 0.91% | -70.8% |
| OVID | New | OVID THERAPEUTICS INC | $11,989,000 | – | 2,888,888 | +100.0% | 0.73% | – |
| KRYS | Sell | KRYSTAL BIOTECH INC | $11,286,000 | +45.0% | 203,788 | -9.1% | 0.69% | -10.5% |
| BEAT | New | BIOTELEMETRY INC | $7,177,000 | – | 155,000 | +100.0% | 0.44% | – |
| FOLD | New | AMICUS THERAPEUTICS INC | $4,945,000 | – | 507,739 | +100.0% | 0.30% | – |
| TPTX | New | TURNING POINT THERAPEUTICS I | $4,441,000 | – | 71,300 | +100.0% | 0.27% | – |
| APLS | New | APELLIS PHARMACEUTICALS INC | $4,134,000 | – | 135,000 | +100.0% | 0.25% | – |
| MOR | New | MORPHOSYS AGsponsored ads | $769,000 | – | 21,561 | +100.0% | 0.05% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -45,000 | -100.0% | -0.06% | – |
| FIXX | Exit | HOMOLOGY MEDICINES INC | $0 | – | -40,557 | -100.0% | -0.07% | – |
| SVRA | Exit | SAVARA INC | $0 | – | -1,568,002 | -100.0% | -0.41% | – |
| MBIO | Exit | MUSTANG BIO INC | $0 | – | -3,160,000 | -100.0% | -1.02% | – |
| ANIP | Exit | ANI PHARMACEUTICALS INC | $0 | – | -142,943 | -100.0% | -1.03% | – |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -1,313,177 | -100.0% | -6.64% | – |
| CPRX | Exit | CATALYST PHARMACEUTICALS INC | $0 | – | -17,875,655 | -100.0% | -9.39% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -6,390,259 | -100.0% | -9.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITED THERAPEUTICS CORP DEL | 29 | Q2 2022 | 15.9% |
| ADMA BIOLOGICS INC | 27 | Q4 2020 | 2.3% |
| RETROPHIN INC | 23 | Q1 2020 | 11.3% |
| ANI PHARMACEUTICALS INC | 23 | Q3 2019 | 7.9% |
| VERICEL CORP | 21 | Q4 2019 | 5.5% |
| AMARIN CORP PLC | 14 | Q3 2019 | 14.4% |
| GLOBUS MED INC | 13 | Q2 2022 | 24.7% |
| ORTHOFIX INTL N V | 13 | Q3 2016 | 9.7% |
| PACIFIC BIOSCIENCES CALIF IN | 13 | Q4 2018 | 9.7% |
| CATALYST PHARM PARTNERS INC | 13 | Q3 2019 | 9.4% |
View Consonance Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DESold out | December 15, 2022 | 0 | 0.0% |
| ADMA BIOLOGICS, INC. | February 14, 2022 | 1,289,481 | 1.4% |
| ASSEMBLY BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| CASI Pharmaceuticals, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Cellectar Biosciences, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Gamida Cell Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| GenMark Diagnostics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Protagonist Therapeutics, IncSold out | February 14, 2022 | 0 | 0.0% |
| Sio Gene Therapies Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| Consonance-HFW Acquisition Corp. | April 27, 2021 | 1,000,000 | 10.4% |
View Consonance Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2022-12-15 |
| SC 13D/A | 2022-12-15 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
| SC 13G/A | 2022-02-14 |
View Consonance Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.